Skip to content

Protecting vulnerable individuals from cytomegalovirus: a new approach

Protecting vulnerable individuals from cytomegalovirus: a new approach 12 June 2024 Dr Matthew Reeves from University College London has received a Paediatric Award Research Project Grant of £210,000 to develop a safe and effective vaccine against cytomegalovirus (CMV) infection in at-risk groups including kidney transplant patients and babies.   The problem  CMV is a common virus…

Read More
Scroll To Top